Pharmacological Treatment
No contributors found.
Release Date:
Pirfenidone is an orally administered antifibrotic agent that inhibits fibroblast proliferation and collagen synthesis. Clinical trials have demonstrated its efficacy in slowing disease progression, reducing decline in lung function, and improving progression-free survival in patients with mild to moderate idiopathic pulmonary fibrosis. Nintedanib is a tyrosine kinase inhibitor that targets multiple growth factor receptors involved [...]
